597. Therapy of Atherosclerosis in Apolipoprotein E-Deficient Mice

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)35610-6
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Acyl-CoA:Cholesterol Acyltransferase Inhibition Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E-Deficient Mice

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

Paradoxical Enhancement of Atherosclerosis by Probucol Treatment in Apolipoprotein E-Deficient Mice.

Journal of Clinical Investigation
Medicine
1997English

Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice

Mediators of Inflammation
ImmunologyCell Biology
2014English

Deficiency of Acyl CoA:cholesterol Acyltransferase 2 Prevents Atherosclerosis in Apolipoprotein E-Deficient Mice

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2003English

Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice

Scientific Reports
Multidisciplinary
2019English

Inhibition of Endoplasmic Reticulum Stress and Atherosclerosis by 2-Aminopurine in Apolipoprotein E-Deficient Mice

ISRN Pharmacology
2013English

Atherosclerosis: The Apolipoprotein E-Deficient Mouse Model Revisited

Microscopy and Microanalysis
Instrumentation
2002English

Mononuclear Cell Therapy Reverts Cuff-Induced Thrombosis in Apolipoprotein E-Deficient Mice

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy